What To Make Of New Positive NSI-189 Results?
Scott Alexander examines the rise, fall, and alleged resurrection of the antidepressant NSI-189, expressing skepticism about its efficacy and the broader challenges in developing new antidepressants.
A thread through the archive
Essays tagged “depression”. Follow an idea across the archive.
Scott Alexander examines the rise, fall, and alleged resurrection of the antidepressant NSI-189, expressing skepticism about its efficacy and the broader challenges in developing new antidepressants.
Scott reviews a theory about serotonin receptors that explains how they help cope with stress, and discusses its implications and limitations.
Scott proposes a speculative theory of depression as pathologically low confidence in neural predictions within the predictive processing framework, explaining how this could account for various depressive symptoms.
Scott Alexander examines the synapse hypothesis of depression, which links decreased synaptogenesis to various depression research findings, and raises questions for future investigation.
Scott Alexander explores why recreational drugs like ketamine and MDMA have shown more promise in treating mental health conditions than intentionally developed pharmaceuticals, suggesting a new direction for drug research.
The post explores a new model for understanding mental disorders as networks of interconnected symptoms rather than discrete diseases with underlying causes.
Scott examines new research on ketamine's antidepressant effects and its implications for understanding depression and evaluating psychiatric literature.
Scott Alexander defends his stance on the 'chemical imbalance' theory of depression, arguing that Mad In America's critique actually supports his view of a more nuanced understanding in psychiatry.
Scott Alexander defends psychiatry's use of 'chemical imbalance' theory, arguing it was meant to emphasize depression's biological basis rather than claiming a simple serotonin deficiency.
Scott Alexander argues that depression and suicide rates are not reliable indicators of societal well-being, critiquing simplistic interpretations of mental health statistics in social comparisons.
Scott Alexander examines the theory linking inflammation to depression, finding it promising but cautioning against overconfidence, and discusses the potential and limitations of anti-inflammatory drugs as depression treatments.
Scott examines the feeling of being a burden in depression, arguing that society owes individuals support and suggesting a need for new ways to find meaning beyond traditional 'contribution'.
Scott explores how antibiotics and antiprotozoal drugs unexpectedly affect mental health, suggesting that random chemicals may frequently influence mental processes.
Scott analyzes various criticisms of antidepressants, concluding they have modest but real benefits over placebo, with important considerations about side effects and efficacy.
Scott explores the fascinating etymology of 'placebo' from medieval funerals to medicine, then discusses the controversial placebo effect in depression treatment.
Scott Alexander offers a comprehensive guide for treating depression, covering professional help, lifestyle changes, and supplements, emphasizing the importance of persistence in finding effective treatments.
Scott Alexander explores a thought experiment based on the Asch conformity experiment to examine the strength and flexibility of personal beliefs and societal norms.
Scott Alexander speculates about mental feedback loops, their relation to various disorders, and how increased self-awareness might accidentally worsen them.
Scott presents a dermatology pop quiz with three statements, asking readers to identify and explain the two true ones.
Scott Alexander defends psychiatric treatment for suicide attempts, arguing that most are impulsive decisions by people with treatable mental disorders rather than rational choices.